等待开盘 04-03 09:30:00 美东时间
0.000
0.00%
An update from SurModics ( ($SRDX) ) is now available. On November 19, 2025, Su...
2025-11-20 06:09
Barrington Research analyst Michael Petusky downgrades Surmodics (NASDAQ:SRDX) from Market Perform to Underperform.
2025-11-15 02:07
ENGN隔夜大涨近47%!膀胱癌基因疗法试验数据表现积极;二手奢侈品在线交易平台REAL涨超38%,Q3业绩超预期及上调财年销售指引>>
2025-11-12 18:55
A U.S. court denied the FTC's bid to block GTCR's $627 million acquisition of Surmodics, clearing the way for the merger to proceed.
2025-11-12 01:00
Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 The S&P 500 and the Nasdaq dipped ...
2025-11-11 23:48
U.S. stocks were mixed, with the Dow Jones index gaining more than 100 points o...
2025-11-11 23:08
Surmodics (SRDX) soared 49% in premarket trading after a federal court rejected a request by the Federal Trade Commission to block its planned sale to GTCR. Judge Jeffrey Cummings denied the FTC's mo...
2025-11-11 21:27
Surmodics, Inc., a provider of medical device and in vitro diagnostic technologies, reported that the United States District Court for the Northern District of Illinois has denied a request by the Fed...
2025-11-11 08:00
Nov 4 (Reuters) - Surmodics Inc SRDX.O: SURMODICS ANNOUNCES OUTCOMES FROM 160 PATIENTS IN PROWL REGISTRY EVALUATING POUNCE™ THROMBECTOMY PLATFORM IN TREATMENT OF REAL-WORLD LIMB ISCHEMIA PRESENTATIONS...
2025-11-04 19:22
Surmodics, Inc. has announced results from an analysis of 160 real-world patients with symptomatic infrainguinal limb ischemia from its PROWL registry study. The results were presented on November 3rd...
2025-11-04 19:15